Corvus Pharmaceuticals Inc. (CRVS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

6,943,654 $37,148,549 0.76%
2.
Samlyn Capital

Robert Pohly

6,667,105 $35,669,011 +48% 0.53%
3. 3,275,616 $17,524,546 15.53%
4. 3,030,011 $16,210,559 -46% 0.03%
5.
Vivo Capital

Albert Cha And Frank Kung

2,234,566 $11,954,928 +50% 1.33%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.73 20,000 153,773 2024-05-06 Filing
$1.73 577,634 577,634 2024-05-06 Filing
$2.45 10,000 10,000 2023-05-15 Filing
$0.79 20,000 Officer 133,773 2022-12-20 Filing
$0.84 4,000 Officer 133,238 2022-12-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.96 2,000,000 Large Shareholder 81,077 2021-10-01 Filing
$5.04 3,000,000 Large Shareholder 2,081,077 2021-09-30 Filing
$6.09 1,109,644 Large Shareholder, Director 6,943,654 2021-09-20 Filing
$6.09 1,109,644 Large Shareholder, Director 6,943,654 2021-09-20 Filing
$5.37 741,440 Large Shareholder 1,389,498 2020-07-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,679,479 $14,335,213 0.21%
2. 2,454,596 $13,132,089 0%
3. 1,581,233 $8,459,597 3.76%
4. 1,072,941 $5,740,235 0%
5. 1,015,083 $5,430,694 0%
News See All